{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-25-007586","form_type":"8-K","ticker":"AEMD","cik":"0000882291","company_name":"AETHLON MEDICAL INC","filed_at":"2025-10-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.453759+00:00","generated_at":"2026-05-17T03:39:08.429651+00:00","sec_items":["3.03","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Aethlon Medical (AEMD) files 1-for-10 reverse stock split effective Oct 16, 2025; split-adjusted trading Oct 20","bullets":["Reverse split effective 10:00 a.m. ET Oct 16, 2025; split-adjusted trading begins Oct 20 under symbol AEMD.","Authorized shares reduced from 60M to 6M; outstanding shares from ~7.6M to ~761k (no fractional shares, rounding up).","Split intended to maintain Nasdaq Listing Rule 5550(a)(2) compliance and manage dilution.","No stockholder approval required under Nevada law; board approved per NRS Section 78.207.","CUSIP changes to 00808Y604; Computershare as transfer agent."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-25-007586","json":"https://secwatch.observer/filing/0001683168-25-007586.json","markdown":"https://secwatch.observer/filing/0001683168-25-007586.md","text":"https://secwatch.observer/filing/0001683168-25-007586.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/882291/000168316825007586/0001683168-25-007586-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/882291/000168316825007586/aemd_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T03:39:08.429651+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b3b3caf4a08a8ee2e1f900c34790a129680ce6a1","claim":"AETHLON MEDICAL INC: Filed a Certificate of Change with the Nevada Secretary of State to effect a 1-for-10 reverse stock split of common stock, reducing authorized shares from 60,000,000 to 6,000,000, effective at 10:00 a.m. ET on October 16, 2025 (effective 2025-10-16).","evidence_excerpt":"On October 14, 2025, Aethlon Medical, Inc., a Nevada corporation (the “Company”), filed a Certificate of Change (the “Certificate of Change”) pursuant to Section 78.209 of the Nevada Revised Statutes (“NRS”) with the Secretary of State of the State of Nevada authorizing a 1-for-10 reverse stock split (the “Reverse Stock Split”) of the Company’s issued and outstanding shares of common stock, $0.001 par value per share (the “Common Stock”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/882291/000168316825007586/0001683168-25-007586-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-10-16"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}